Related references
Note: Only part of the references are listed.Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria
Thanaporn Wattanakul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana et al.
LANCET INFECTIOUS DISEASES (2021)
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis
Xin Hui S. Chan et al.
PLOS MEDICINE (2021)
Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children
Junjie Ding et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study
Ebenezer Baba et al.
LANCET (2020)
Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial
Oriane Sottas et al.
PLOS ONE (2019)
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Palang Chotsiri et al.
NATURE COMMUNICATIONS (2019)
Seasonal malaria chemoprevention combined with community case management of malaria in children under 10 years of age, over 5 months, in south-east Senegal: A cluster-randomised trial
Jean Louis A. Ndiaye et al.
PLOS MEDICINE (2019)
Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
Palang Chotsiri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection
Pengxing Cao et al.
ELIFE (2019)
Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria
Mine de Kock et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns
James Watson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing
Ali Mohamed Ali et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
Frank Kloprogge et al.
PLOS MEDICINE (2018)
Controlled Human Malaria Infection: Applications, Advances, and Challenges
Danielle I. Stanisic et al.
INFECTION AND IMMUNITY (2018)
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial
Junior R. Matangila et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Does antimalarial mass drug administration increase or decrease the risk of resistance?
Nicholas J. White
LANCET INFECTIOUS DISEASES (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
Brian Greenwood et al.
MALARIA JOURNAL (2017)
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis
Richard M. Hoglund et al.
PLOS MEDICINE (2017)
Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine
Jesmin Permala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
Issaka Zongo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Impact of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren: A Randomized, Placebo-Controlled Trial
Joaniter I. Nankabirwa et al.
CLINICAL INFECTIOUS DISEASES (2014)
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention
Martin Bergstrand et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand
J. Tarning et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Effect of Single Nucleotide Polymorphisms in Cytochrome P450 Isoenzyme and N-Acetyltransferase 2 Genes on the Metabolism of Artemisinin-Based Combination Therapies in Malaria Patients from Cambodia and Tanzania
Eva Maria Staehli Hodel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Population Pharmacokinetic and Pharmacodynamic Modeling of Amodiaquine and Desethylamodiaquine in Women with Plasmodium vivax Malaria during and after Pregnancy
Joel Tarning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Randomized, Double-Blind, Placebo-Controlled Trial of Monthly versus Bimonthly Dihydroartemisinin-Piperaquine Chemoprevention in Adults at High Risk of Malaria
Khin Maung Lwin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Population Pharmacokinetics and Pharmacodynamics of Piperaquine in Children With Uncomplicated Falciparum Malaria
J. Tarning et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Estimating the potential public health impact of seasonal malaria chemoprevention in African children
Matthew Cairns et al.
NATURE COMMUNICATIONS (2012)
Pharmacokinetic Properties of Conventional and Double-Dose Sulfadoxine-Pyrimethamine Given as Intermittent Preventive Treatment in Infancy
Sam Salman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children
M. Cairns et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Incidence of Malaria and Efficacy of Combination Antimalarial Therapies over 4 Years in an Urban Cohort of Ugandan Children
Tamara D. Clark et al.
PLOS ONE (2010)
Efficacy, Safety, and Tolerability of Three Regimens for Prevention of Malaria: A Randomized, Placebo-Controlled Trial in Ugandan Schoolchildren
Joaniter Nankabirwa et al.
PLOS ONE (2010)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children
Badara Cisse et al.
PLOS ONE (2009)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi
JG Kublin et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Share Paper
